Ali Jalali, PhD

Highlights

1
The Journal of pediatrics · 2020
AJAli Jalali
PMID: 32659229PMCID: PMC7686158DOIFirst author43 citations
2
JAMA network open · 2023
JCJim C. Hu DMDaniel Margolis BSBruce Schackman AJAli Jalali
PMID: 38019516PMCID: PMC10687655DOISenior author2 citations
3
Drug and alcohol dependence · 2020
AJAli Jalali BSBruce Schackman SMSean M. Murphy
PMID: 32777692PMCID: PMC7502461DOIFirst author22 citations

Publications

48

Funding

20 View NIH portfolio on RePORTER ↗

Active

15 grants

Co-I
The Ohio Valley Node of the Clinical Trials Network - MOMs Project
National Institute on Drug Abuse · 2025–2032 · via University of Cincinnati
UG1DA013732-26
Sub-PI
Testing MOUD Scale-Up Strategies in Criminal Legal Settings
National Institute on Drug Abuse · 2025–2030 · via University of Wisconsin
UM1DA064515-02
Sub-PI
NY MOVES: Evaluating the Impact of New York's Methadone Outreach VEhicleS
National Institute on Drug Abuse · 2025–2030 · via New York University
R01DA063711-02
Sub-PI
Improving Jail Response to the Overdose Crisis: A Hybrid Trial of Jail ECHO to Improve MOUD Implementation and Public Health Outcomes
National Institute on Drug Abuse · 2025–2030 · via University of Massachusetts Medical School
RM1DA064507-02
Co-I
Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Supporting Financial Sustainability, Advanced Methods, and Knowledge Translation
National Institute on Drug Abuse · 2025–2030
P30DA040500-12
MPI
NY Community-Hospital-Academic Maternal Health Equity Partnerships (NY-CHAMP) Component: Project 2 - Policy solutions for addressing structural racism in maternal heath disparities
Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023–2029 · via Columbia University
U54HD113172-03
Co-I
A Randomized Controlled Trial of sublingual versus extended-release buprenorphine with individuals leaving Carceral Settings access, quality, and spending
National Institute on Drug Abuse · 2023–2028 · via Friends Research Institute, Inc.
R01DA058674-01
Sub-PI
NAVIGATE Kidney: A Multi-Level Intervention to Reduce Kidney Health Disparities
National Institute of Diabetes and Digestive and Kidney Diseases · 2023–2028 · via University of Colorado Denver Anschutz Medical Campus
U01DK137272-03
Sub-PI
Leveraging social determinants via artificial intelligence and peer coaching to address racial disparities in primary care among people who use opioids
Agency for Healthcare Research and Quality · 2023–2027 · via Friends Research Institute, Inc.
R18HS029783-02
PI
Novel Econometric Research Designs (NERD) to Help End Addiction Long-term
National Center for Advancing Translational Sciences · 2024–2027
DP2DA062283-01
Co-I
JCOIN Phase II Economic Research Resource Center
National Institute on Drug Abuse · 2025–2027
U24DA064506-01
Sub-PI
Reducing Addiction through Prevention Infrastructure Development (RAPID)
National Institute on Drug Abuse · 2025–2026 · via Wayne State University
R61DA063683-01
PI
The Economic Viability and Value of Implementing an Inpatient Addiction Consult Model in Public Hospital Systems for Patients with Opioid Use Disorder
National Institute on Drug Abuse · 2023–2026
R03DA057465-02
Co-I
A Randomized Controlled Trial of sublingual versus extended-release buprenorphine with individuals leaving Carceral Settings
National Institute on Drug Abuse · 2022–2026 · via Friends Research Institute, Inc.
UG1DA050077-04S1
Co-I
Greater Southern California Node of the Clinical Trials Network
National Institute on Drug Abuse · 2022–2026 · via University of California, Los Angeles
UG1DA049435-04

Completed grants (5)

PI
Health-related quality of life among persons involved in the criminal-legal system with a history of opioid use disorder
Chestnut Health Systems Inc. · 2023–2025Contract
SRA 230561-02
Co-I
Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populations
National Institute on Drug Abuse · 2020–2025 · via Yale University
U01DA053039-01
Co-I
Comparative- and cost-effectiveness research determining the optimal intervention for advancing transgender women living with HIV to full viral suppression
National Institute on Drug Abuse · 2023–2025 · via Friends Research Institute, Inc.
R01DA056287-01
Co-I
Optimizing PrEP Implementation and Cost-effectiveness among Sexual and Gender Minority Individuals with a Substance Use Disorder
National Institute on Drug Abuse · 2022–2025 · via Friends Research Institute, Inc.
R01DA056888-01
Co-I
DAT-18-06 Prevention and Rescue Of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies (PROFOUND)
National Institute on Drug Abuse · 2019–2025
U01DA047408-01A1

Clinical research

1

Active

1 study

PI
Economic evaluation of NY MOVES: Evaluating the Impact of New York's Methadone Outreach VEhicleS
New York University School of Medicine · OPEN TO ACCRUAL (as of 2026)

News mentions

1 View all WCM news ↗

Dr. Ali Jalali Receives NIH Director’s New Innovator Award
October 10, 2024
Dr. Ali Jalali, an assistant professor of population health sciences at Weill Cornell Medicine, was awarded the prestigious National Institutes of Health Director’s New Innovator Award through its Helping to End Addiction Long-term (HEAL) Initiative.

Mentoring

1

CC
Callista Clairmont
MD mentee · Class of 2026